Wholly-Owned Subsidiary Halucenex Life Sciences Inc. Achieves Remission In 80% Of First Five Patients In Phase II Clinical Trial Cannabis Investing News
ECS Botanics Secures a $24 Million Offtake Agreement with MediCann Health for Supply of Medicinal Cannabis Cannabis Investing News
Melodiol Subsidiary Mernova Medicinal Inc. Scales Up As Q3 Sales Momentum Accelerates Cannabis Investing News
Melodiol To Streamline Portfolio With Up To A$30M Asset Sale To Us Listed Panacea – Maintaining Significant Stake In Spin-Off Vehicle Cannabis Investing News
